How Long Does a B12 Shot Last? What the Data Shows

Half or more of an injected cyanocobalamin dose can reach the urine within 48 hours, yet the labeled maintenance schedule for pernicious anemia is one injection a month for life¹. The liver stores what is retained, and hydroxocobalamin is retained longer: about 75% versus 20% in a 1964 study^{1, 2}.

How soon you feel better depends on what you were missing. Blood counts start recovering within about a week, while nerve symptoms take months^{3, 4}. Our pages on vitamin B12 and B12 deficiency cover the wider evidence.

Roughly half or more of an injected cyanocobalamin dose may be excreted within 48 hours¹, and the amount retained differs by form. Three sources measured it:

• FDA label, 100 or 1,000 mcg: plasma levels peak within 1 hour of an intramuscular injection, and 50% to 98% of the dose may appear in urine within 48 hours, mostly in the first 8 hours¹.
• 1964, about 1 mg into muscle: normal subjects excreted about 80% of cyanocobalamin in urine within 24 hours, against about 25% of hydroxocobalamin. That is a retention of roughly 20% versus 75%².
• 1961, 500 or 1,000 µg: 16% and 27% of hydroxocobalamin were lost in 72 hours of urine, against 60% and 69% of cyanocobalamin⁵.

Urine loss is not the same as the effect wearing off. The liver is the main storage organ¹, and the body holds 1 to 5 mg of B12, about 1,000 to 2,000 times a typical day's intake, so deficiency symptoms take years to appear⁶. After a shot, what matters is how much is retained and stored, not how long it circulates.

Does methylcobalamin last longer?

We found no human data on how long injected methylcobalamin is retained. A 2015 review of the biochemistry concluded that methylcobalamin and adenosylcobalamin are unlikely to beat cyanocobalamin or hydroxocobalamin for treating deficiency, because cells process all of these forms by the same route⁷.

Blood counts move first, within days to weeks. Nerve symptoms follow over months. This is the timeline from the sources we read:

• Days 5 to 7: the label advises repeating hematocrit and reticulocyte counts daily from the fifth to seventh day of therapy¹. Reticulocytes (new red blood cells) peaked at 1 week in 28 children given oral methylcobalamin³.
• Days 7 to 28: in a 2026 randomized trial of 153 adults, counts were taken on days 7, 14 and 28, and intramuscular B12 produced the largest reticulocyte rise. By day 28 hemoglobin had risen 2.18 g/dL after intramuscular B12, 1.80 g/dL after intravenous and 2.48 g/dL after intranasal, with no significant difference between routes after adjustment⁸.
• Month 1, blood levels: oral cyanocobalamin, 250 to 1,000 µg a day, normalized serum B12 in 87% of 30 patients who could not absorb B12 from food⁹.
• Months 1 to 3, nerves: in a review of 153 episodes of B12 deficiency affecting the nervous system, some response was always seen during the first 3 months of treatment⁴.
• Longer follow-up: of 121 of those episodes with adequate follow-up, 47.1% recovered completely, with follow-up of unstated length⁴. In a separate cohort of 63 patients, 54% had improved after at least 6 months of injections¹⁰. The studies define improvement differently, so the figures are not directly comparable.

Why do some people respond slowly?

Delay before treatment is the best-documented factor. In the 153-episode review, improvement was inversely related to how long symptoms had lasted, and the median delay before treatment was 4 months⁴. In the 2026 trial, a lower starting hemoglobin and a vegan diet predicted a larger hemoglobin gain, and the route did not matter⁸.

They are worth it if you are deficient. Injections bypass absorption problems, which is why the label lists pernicious anemia, gastrointestinal surgery and similar malabsorption as the indications¹. For people who are not clearly deficient, the trials are mostly null, though few and limited:

• Meta-analysis, 16 trials, 6,276 people: no evidence that B12 improves cognition or depression in people without overt deficiency or advanced neurological disorders. Only one study reported fatigue, so it could not be analyzed¹¹.
• 95 adults with IBS or IBD, fatigue and normal B12: oral B12, 1,000 µg a day for 8 weeks, changed fatigue scores by -8.1, against -8.3 on placebo¹².
• 140 adults with a modestly raised methylmalonic acid, a marker of functional deficiency: weekly injections for 4 weeks improved only general health among 8 quality-of-life dimensions (P = 0.03)¹³. Cognition and depression scores did not change at 3 months¹⁴.

The NIH Office of Dietary Supplements adds that B12 does not appear to improve athletic performance in people with sufficient B12 status⁶. If tiredness is your main symptom, see our pages on chronic fatigue and energy production.

The vitamin has low toxicity, and the NIH sets no tolerable upper intake level⁶. The FDA-labeled injection still carries warnings¹:

• Allergic reactions: anaphylactic shock and death have been reported after parenteral B12, and sensitivity to cobalt or B12 is a contraindication.
• Leber's disease: patients with early Leber's disease (hereditary optic nerve atrophy) suffered severe, swift optic atrophy.
• Severe megaloblastic anemia: hypokalemia and sudden death may occur when it is treated intensely. In pernicious anemia the label says to watch serum potassium closely for the first 48 hours.
• Kidney impairment: the product contains aluminum, which may reach toxic levels with prolonged parenteral use if kidney function is impaired.

Four patients in the 153-episode nerve review had transient neurologic worsening soon after starting cyanocobalamin, then recovered⁴. Tell your prescriber about any new symptoms after your first shots.

Your prescriber sets the schedule. For pernicious anemia the label gives 100 mcg daily for 6 or 7 days, then alternate days for seven doses, then every 3 to 4 days for another 2 to 3 weeks, followed by 100 mcg monthly for life. For deficiency with normal absorption it says chronic treatment should be oral¹.

Hydroxocobalamin schedules are spaced further apart. In a 1987 series of 17 patients, 1 mg every three months was given for 8 to 20 years after an initial depot treatment of one or two series of five injections on alternate days. One initial series followed by 3-monthly injections kept serum cobalamin in the normal range¹⁵.

Hydroxocobalamin is retained longer than cyanocobalamin^{2, 5}, so longer spacing is plausible, though these studies did not test intervals. The other reason is the cause. Pernicious anemia is an irreversible autoimmune disease of the stomach lining⁶, and the label says injections are then needed for the remainder of life¹. The 2014 British guideline points prescribers to the national formulary for regimens¹⁶. For the deficiency itself, see our page on B12 for B12 deficiency.

Some prescribers now offer high-dose tablets. The 2014 British guideline says oral therapy may be suitable provided appropriate doses are taken and compliance is not an issue¹⁶. The trial evidence is small and mostly low quality:

• Cochrane review, 3 trials, 153 people, 3 to 4 months: oral 1,000 µg a day was not clinically different from injections for serum B12. One trial using 2,000 µg a day gave a mean 680 pg/mL higher level than injections¹⁷.
• Earlier review, 2 trials, 108 people recruited, 93 followed up: in one trial (33 people followed up), serum B12 at 4 months was 1,005 pg/mL with oral dosing against 325 pg/mL with injections. In the other, levels rose in both groups¹⁸.
• 50 people after gastric bypass: oral methylcobalamin 1,000 µg a day and injected hydroxocobalamin every two months both normalized B12 in everyone over 6 months¹⁹.

The limits matter. No Cochrane trial reported clinical signs, symptoms or quality of life¹⁷. The label calls oral absorption too undependable to rely on in pernicious anemia or other malabsorption¹, so do not switch from injections without medical advice.

Do not wait for a trial-length timeline. Deficiency symptoms include fatigue, neurological changes, megaloblastic anemia, a sore tongue, palpitations and low blood cell counts, and they can occur without anemia⁶. In the 153-episode review, 27.4% of episodes had a normal hematocrit⁴.

The label warns that deficiency allowed to progress for longer than 3 months may produce permanent degenerative lesions of the spinal cord¹. The British guideline says that when a test result conflicts with strong clinical features, treatment should not be delayed¹⁶. Our pages cover B12 for numbness, tingling and peripheral neuropathy.

Possibly at high doses, but the evidence is one small, preliminary trial. In 20 healthy adults given 3 mg of cyanocobalamin or methylcobalamin for 14 days, both forms increased activity between 11 pm and 7 am, and sleep time fell significantly only with methylcobalamin²⁰.

That dose is more than 1,000 times the 2.4 µg adult RDA⁶, and the study says nothing about a single shot.

Use these rules to judge whether a course is working:

• Get a baseline. Serum B12 is the first-line test and methylmalonic acid can clarify unclear results¹⁶.
• Check blood counts early. The label advises repeat counts from days 5 to 7¹.
• Judge nerve symptoms over months. Some response appeared within 3 months in the nerve review⁴.
• Do not expect an energy lift from extra B12 alone. Without overt deficiency, the trials above found none for fatigue, mood or thinking^{11, 12}.
• Ask why you are low. Causes include poor absorption from food, missing intrinsic factor, gastrointestinal surgery, metformin or proton pump inhibitors, and a diet without animal foods⁶. See metformin and vitamin B12 and vitamin B12 foods.

Supplements in this guide

• Vitamin B12

Related conditions

• B12 Deficiency
• Anemia

We screened more than 100 search results from the Firecrawl research index (PubMed and related sources) across six framings, from oral versus injected B12 to nerve recovery and guidelines. We cited 16 PubMed abstracts and 2 research-index excerpts, the NIH Office of Dietary Supplements fact sheet, and the FDA-labeled cyanocobalamin injection label on DailyMed. We prioritized systematic reviews and randomized trials in adults.

Limits: the two retention studies are from 1961 and 1964, and PubMed carries no abstract for them, so we cite only the abstract text in the research index, not the full papers. Several timeline studies are small or in children. We found no human retention data for injected methylcobalamin, and we found no sourced answers on aftercare restrictions or hair growth. An independent reviewer checked the draft against its sources, and we corrected what the sources confirmed. Researched 30 October 2026.

1. DailyMed. Cyanocobalamin Injection, USP (prescription drug label, revised 02/2024). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2117af8a-723f-4e2f-98a6-83ad2c423751
2. HERTZ H, et al. STUDIES ON VITAMIN B12 RETENTION. COMPARISON OF RETENTION FOLLOWING INTRAMUSCULAR INJECTION OF CYANOCOBALAMIN AND HYDROXOCOBALAMIN. Scand J Haematol. 1964;1:5-15. doi:10.1111/j.1600-0609.1964.tb00001.x
3. Verma D, et al. Efficacy of oral methylcobalamin in treatment of vitamin B12 deficiency anemia in children. Pediatr Blood Cancer. 2017;64(12). doi:10.1002/pbc.26698
4. Healton EB, et al. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70(4):229-45. doi:10.1097/00005792-199107000-00001
5. GLASS GB, et al. Hydroxocobalamin. I. Blood levels and urinary excretion of vitamin B12 in man after a single parenteral dose of aqueous hydroxocobalamin, aqueous cyanocobalamin and cyanocobalamin zinc-tannate complex. Blood. 1961;18:511-21. https://pubmed.ncbi.nlm.nih.gov/13899122/
6. National Institutes of Health, Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
7. Obeid R, et al. Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Mol Nutr Food Res. 2015;59(7):1364-72. doi:10.1002/mnfr.201500019
8. Singh SK, et al. Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial. Am J Hematol. 2026;101(9):2343-2352. doi:10.1002/ajh.70433
9. Andrès E, et al. Efficacy of short-term oral cobalamin therapy for the treatment of cobalamin deficiencies related to food-cobalamin malabsorption: a study of 30 patients. Clin Lab Haematol. 2003;25(3):161-6. doi:10.1046/j.1365-2257.2003.00515.x
10. Aaron S, et al. Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India. 2005;53(1):55-8; discussion 59. doi:10.4103/0028-3886.15057
11. Markun S, et al. Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression. Nutrients. 2021;13(3). doi:10.3390/nu13030923 Our study summary.
12. Scholten AM, et al. Surplus vitamin B12 use does not reduce fatigue in patients with Irritable Bowel Syndrome or inflammatory bowel disease: A randomized double-blind placebo-controlled trial. Clin Nutr ESPEN. 2018;23:48-53. doi:10.1016/j.clnesp.2017.10.004 Our study summary.
13. Hvas AM, et al. Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med. 2003;253(2):146-52. doi:10.1046/j.1365-2796.2003.01067.x
14. Hvas AM, et al. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord. 2004;81(3):269-73. doi:10.1016/S0165-0327(03)00169-1
15. Skouby AP. Hydroxocobalamin for initial and long-term therapy for vitamin B12 deficiency. Acta Med Scand. 1987;221(4):399-402. doi:10.1111/j.0954-6820.1987.tb03362.x
16. Devalia V, et al. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513. doi:10.1111/bjh.12959
17. Wang H, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3(3):CD004655. doi:10.1002/14651858.CD004655.pub3 Our study summary.
18. Butler CC, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract. 2006;23(3):279-85. doi:10.1093/fampra/cml008
19. Schijns W, et al. Efficacy of oral compared with intramuscular vitamin B-12 supplementation after Roux-en-Y gastric bypass: a randomized controlled trial. Am J Clin Nutr. 2018;108(1):6-12. doi:10.1093/ajcn/nqy072
20. Mayer G, et al. Effects of vitamin B12 on performance and circadian rhythm in normal subjects. Neuropsychopharmacology. 1996;15(5):456-64. doi:10.1016/S0893-133X(96)00055-3